Treatment of childhood obesity in obese families

Dan Nemet1, Neomi Barzilay-Teeni, Alon Eliakim

  • 1Child Health & Sports Center, Department of Pediatrics, Meir General Hospital, Kfar Saba, Israel. dnemet@gmail.com

Insights

Intensive family-based interventions can help obese children from obese families lose weight and improve fitness. This approach is crucial for managing childhood obesity in families with shared weight challenges.

Area of Science:

  • Pediatrics
  • Public Health
  • Genetics

Background:

  • Parental obesity negatively impacts the success of standard childhood obesity programs.
  • Family-based interventions are essential for obese children from obese families.

Purpose of the Study:

  • To assess an intense 3-month family-based intervention for obese children from obese families.
  • Compared intervention group with a control group receiving no intervention.

Main Methods:

  • Randomized controlled trial with 22 obese children (BMI >95th percentile) from obese families (parental BMI >27 kg/m2).
  • Intervention included dietary, behavioral, and physical activity components.
  • Measurements included anthropometrics, body composition, habits, and fitness before and after 3 months.

Main Results:

  • Intervention group showed significant weight loss (-0.2 kg vs 1.7 kg) and BMI percentile reduction (-1.4% vs -0.1%).
  • Reduced screen time significantly in the intervention group (-2.2 h/day vs 0.1 h/day).
  • Improved fitness levels, indicated by increased endurance time (181s vs 26s), in the intervention group.

Conclusions:

  • Obese children from obese families present unique treatment challenges.
  • Family-oriented, multidisciplinary weight management interventions are recommended for this population.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Family Therapy01:30

Family Therapy

Family therapy conceptualizes psychological challenges as arising from dysfunctional interactions within the family unit, rather than as isolated issues within individuals. This approach seeks to address and transform the patterns of communication, roles, and relationships within families to promote healthier dynamics and emotional well-being for all members.
Strategic Family Therapy
Strategic family therapy emphasizes resolving communication barriers and improving problem-solving abilities...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...